tiprankstipranks
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market

Telomir Pharmaceuticals, Inc. (TELO) Income Statement

14 Followers

Telomir Pharmaceuticals, Inc. Income Statement

Last quarter (Q ), Telomir Pharmaceuticals, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Telomir Pharmaceuticals, Inc.'s net income was $-1.71M. See Telomir Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
----
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 954.15K$ 3.94M$ 854.15K$ 138.13K
Operating Income
$ -954.15K$ -3.97M$ -854.15K$ -138.13K
Net Non Operating Interest Income Expense
$ -757.17K$ -1.64M--
Other Income Expense
-$ 7.49M--
Pretax Income
$ -1.71M$ -13.10M$ -854.15K$ -138.13K
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -1.71M$ -13.07M$ -854.15K$ -138.13K
Basic EPS
$ -0.06$ -0.48$ -0.03-
Diluted EPS
$ -0.06$ -0.45$ -0.03-
Basic Average Shares
$ 29.61M$ 27.30M$ 29.61M$ 29.61M
Diluted Average Shares
$ 29.61M$ 29.02M$ 29.61M$ 29.61M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 954.15K$ 3.94M$ 854.15K$ 138.13K
Net Income From Continuing And Discontinued Operation
$ -1.71M$ -13.07M$ -854.15K$ -138.13K
Normalized Income
-$ -10.35M--
Interest Expense
----
EBIT
-$ -11.46M--
EBITDA
-$ -9.85M--
Currency in USD

Telomir Pharmaceuticals, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis